Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 68

Results For "IP"

10247 News Found

Ipsen enters exclusive worldwide tie-up with Accent for its pre-clinical R&D oncology pipeline
Biotech | October 18, 2021

Ipsen enters exclusive worldwide tie-up with Accent for its pre-clinical R&D oncology pipeline

Ipsen obtains an exclusive license to develop, manufacture and commercialize a pre-clinical stage METTL3-inhibitor programme


Roche’s 8-year safety data of Ocrevus shows reduced risk in multiple sclerosis patients
Biotech | October 13, 2021

Roche’s 8-year safety data of Ocrevus shows reduced risk in multiple sclerosis patients

New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials


HCL expands its partnership with Google Cloud to focus on healthcare and life sciences
Digitisation | October 12, 2021

HCL expands its partnership with Google Cloud to focus on healthcare and life sciences

HCL will establish a joint centre of excellence (CoE) for Google Cloud with industry subject matter experts and Google Cloud-certified ideapreneurs


Tarsons earmarks funds from IPO to double capacity at its Panchla facility
News | October 12, 2021

Tarsons earmarks funds from IPO to double capacity at its Panchla facility

An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion


IPM growth led by Covid  driven products to taper off in Q2FY22: Nirmal Bang
News | October 06, 2021

IPM growth led by Covid driven products to taper off in Q2FY22: Nirmal Bang

In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report


Lupin receives tentative approval for Brexpiprazole tablets
Drug Approval | October 06, 2021

Lupin receives tentative approval for Brexpiprazole tablets

This product will be manufactured at Lupin’s Pithampur facility In India


Mawi DNA announce partnership with FUJIFILM
Medical Device | October 05, 2021

Mawi DNA announce partnership with FUJIFILM

FUJIFILM will distribute iSWAB bio sampling technologies in Japan


Samina Hamied of Cipla is the new VP of the IPA for 2021-23
Appointment | October 04, 2021

Samina Hamied of Cipla is the new VP of the IPA for 2021-23

Cipla is a leading global pharma company


Lilly to transfer rights of two diabetes drugs to Cipla in India
Drug Approval | October 04, 2021

Lilly to transfer rights of two diabetes drugs to Cipla in India

Lilly will continue to maintain its existing operating model for the remaining portfolio of products


Samir Mehta of Torrent is the new President of IPA for 2021-23
Appointment | October 04, 2021

Samir Mehta of Torrent is the new President of IPA for 2021-23

Torrent is one of India's fastest-growing pharma majors